Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 7906 AL 7920

Experimental Evidence of Caffeic Acid's Neuroprotective Activity in Alzheimer's Disease: In Vitro, In Vivo, and Delivery-Based Insights

Kowalczyk A, Tuberoso CIG, Jerković I.

Medicina (Kaunas). 2025 Aug 8;61(8):1428. doi: 10.3390/medicina61081428.

Network Analysis of Delusion Subtypes in Amyloid PET-Positive, Drug-Naïve Alzheimer's Disease Patients

Yang Y, Kwak YT.

Am J Geriatr Psychiatry. 2025 Nov;33(11):1207-1217. doi: 10.1016/j.jagp.2025.04.210. Epub 2025 Apr 22.

Changes in Daily Functioning in Association With Tau and Amyloid Among Unimpaired Older Adults With and Without Elevated Amyloid

Dubbelman MA, Liu A, Donohue MC, Langford O, Raman R, Rentz DM, Amariglio R, Sperling RA, Aisen PS, Marshall GA; as the A4 Study team.

Neurology. 2025 Jun 24;104(12):e213775. doi: 10.1212/WNL.0000000000213775. Epub 2025 May 29.

Unraveling the Role of LRP1 in Alzheimer's Disease: A Focus on Aβ Clearance and the Liver-Brain Axis

Yang W, Wei Z, Wang T.

J Mol Neurosci. 2025 Apr 1;75(2):43. doi: 10.1007/s12031-025-02339-2.

Bridging the gap: Efficacy of combined therapies for cognitive, behavioral, and functional outcomes in Alzheimer's disease - results from a systematic review and network meta-analysis

Boongird C, Anothaisintawee T, Tearneukit W, Wongpipathpong W, Suthutvoravut U, Thongpan M, Pongsettakul N, Attia J, McKay GJ, Rattanasiri S, Thakkinstian A.

J Alzheimers Dis. 2025 Nov;108(2):509-521. doi: 10.1177/13872877251378354. Epub 2025 Oct 3.

Exploring the efficacy and safety of lecanemab in the management of early Alzheimer's disease: A systematic review of clinical evidence

Ashmawy RE, Okesanya OJ, Ukoaka BM, Daniel FM, Ezedigwe SG, Agboola AO, Ahmed MM, Ogaya JB, Amisu BO, Adigun OA, Oluwakemi OG, Hamza AM, Mourid MR, Kouwenhoven M, Lucero-Prisno DE 3rd.

J Alzheimers Dis. 2025 Jun;105(3):714-728. doi: 10.1177/13872877251331640. Epub 2025 Apr 15.

Efficacy and APOE ε4-stratified risk of donanemab in Alzheimer's disease: A systematic review and meta-analysis of randomized clinical trials

Pereira da Silva AM, Falcão L, Virgilio F, Rodrigues Menezes I, Leite M, Farias E, Nascimento M, Lee Han M, Mota Telles JP, de Souza Franco E, de Sousa Maia MB.

J Alzheimers Dis. 2025 Sep;107(2):477-493. doi: 10.1177/13872877251361044. Epub 2025 Sep 1.

Alzheimer's Disease and Circulatory Imbalance of Toxic Heavy Metals: A Systematic Review and Meta-analysis of Clinical Studies

Kooshki A, Farmani R, Mehrpour O, Naghizadeh A, Amirabadizadeh A, Kavoosi S, Vohra V, Nakhaee S.

Biol Trace Elem Res. 2025 Apr;203(4):1871-1885. doi: 10.1007/s12011-024-04326-x. Epub 2024 Jul 30.

Therapeutic potential of traditional chinese medicine polysaccharides in alzheimer's disease via modulation of gut microbiota: A review

Wang T, Gao C, Dong X, Li L.

Int J Biol Macromol. 2025 Sep;321(Pt 2):146160. doi: 10.1016/j.ijbiomac.2025.146160. Epub 2025 Jul 18.

Lower baseline amyloid beta burden is associated with greater percent of amyloid beta positron emission tomography reduction and better clinical outcomes in the aducanumab Phase 3 trials ENGAGE and EMERGE in early Alzheimer's disease

Burton J, Brothers HM, Hutchison RM, Murphy J, Sun T, Dent G, Curiale G, Kowalski K.

J Prev Alzheimers Dis. 2025 Aug;12(7):100202. doi: 10.1016/j.tjpad.2025.100202. Epub 2025 May 24.

NeuroEPO plus (NeuralCIM(®)) in Alzheimer's disease: Post-trial observational follow-up study

Sosa Pérez S, Urrutia Amable N, Viada González CE, Lorenzo-Luaces P, Sánchez Valdés L, Crombet Ramos T, León Monzón K, Rodríguez Obaya TJ, Pérez Ruiz L.

J Alzheimers Dis. 2025 Dec;108(3):1422-1435. doi: 10.1177/13872877251386885. Epub 2025 Oct 22.

Comparison of the efficacy of updated drugs for the treatment on the improvement of cognitive function in patients with Alzheimer 's disease: A systematic review and network meta- analysis

Cao W, Zhu B, Liu Z, Jia X, Zhao H, Gu N, Chang H, Xi J, Li R, Guo K, Shen J, Ding L, Sun F, Di Z.

Neuroscience. 2025 Jan 26;565:29-39. doi: 10.1016/j.neuroscience.2024.11.029. Epub 2024 Nov 15.

Associations between selected genetic variants and lipid profile variability in response to statins in Alzheimer's disease: a prospective observational study

Oliveira FF, Almeida SS, Chen ES, Bertolucci PHF, Smith MC.

Sao Paulo Med J. 2025 Aug 15;143(4):e2024160. doi: 10.1590/1516-3180.2024.0160.27112024. eCollection 2025.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias